A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)
Clinical trial NCT06561074 · RECRUITING
Trial details
- NCT number
- NCT06561074
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-25
- Primary completion
- 2029-12-31
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.